Aurobindo Pharma Buyback Record Date 2024, Price, Entitlement Ratio

Last updated on August 2, 2024

Aurobindo Pharma Buyback Record Date is 30 July 2024. 

Aurobindo Pharma is a leading Indian pharmaceutical company founded in 1986. Aurobindo manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs) across major therapeutic areas such as antibiotics, antiretrovirals, central nervous system, cardiovascular, anti-diabetics, and more.

The company has a large diversified product portfolio with over 870 marketed drugs and a strong global presence, exporting to over 150 countries. Aurobindo operates state-of-the-art manufacturing facilities approved by leading regulatory bodies like the US FDA, UK MHRA, TGA Australia, and EMA, as well as R&D centers leveraging a team of over 1,700 expert scientists and analysts globally.

Aurobindo Pharma Buyback Record Date, Other Details

Aurobindo Pharma Buyback Dates (Timeline)

Aurobindo Pharma Buyback 2024 Documents

Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback

Aurobindo Pharma Buyback Entitlement Ratio

A small shareholder is defined as a shareholder who holds shares worth less than INR 2,00,000 as of the record date.

Aurobindo Pharma Financial Performance

Calculation of Investment in Buyback

Aurobindo Pharma Buyback Acceptance Ratio

Registrar of Aurobindo Pharma Buyback 2024

KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com

Manager of Aurobindo Pharma Buyback 2024

AXIS CAPITAL LIMITED
1st floor, Axis House, C-2 Wadia International Centre,
P.B. Marg, Worli, Mumbai – 400025
Tel: +91 22 4325 2183
E-mail: [email protected]
Website: www.axiscapital.co.in

The Process to Participate in Aurobindo Pharma Buyback

All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.

The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.

The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.

Frequently Asked Questions